Transcoronary ethanol for incessant epicardial ventricular tachycardia

Gabus, Vincent; Jeanrenaud, Xavier; Eeckhout, Éric; Pruvot, Étienne

doi:10.1016/j.hrthm.2013.09.058

Cited by 13 publications

(5 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Arrhythmia surgery must be considered in such cases (see Chapter V ). Moreover, several special ablation techniques are available, including bipolar RF ablation (not covered by Japan's National Health Insurance), 1084 , 1085 simultaneous unipolar RF ablation, 1086 chemical (ethanol) ablation (not covered by Japan's National Health Insurance), 1087 , 1088 , 1089 , 1090 and needle ablation (unapproved). 1091 …”

Section: Catheter Ablationmentioning

confidence: 99%

JCS/JHRS 2019 guideline on non‐pharmacotherapy of cardiac arrhythmias

Nogami¹,

Kurita²,

Abe³

et al. 2021

Journal of Arrhythmia

104

View full text Add to dashboard Cite

Section: Catheter Ablationmentioning

confidence: 99%

JCS/JHRS 2019 guideline on non‐pharmacotherapy of cardiac arrhythmias

Nogami¹,

Kurita²,

Abe³

et al. 2021

Journal of Arrhythmia

104

View full text Add to dashboard Cite

“…Complete atrioventricular block occurred in five patients. Although far from uniformly effective, ethanol ablation continues to represent a viable treatment option for patients with prior RFA failures, and periodically, case reports of the bail-out use of ethanol ablation for ventricular tachycardia refractory to RFA continue to appear in the literature [29-31]. The success of the procedure critically relies on the accurate identification of an arterial branch that supplies the arrhythmogenic ventricular tissue and the suitability of that branch to selective cannulation.…”

Section: Ventricular Tachycardia Ablation With Ethanolmentioning

confidence: 99%

Ethanol for the treatment of cardiac arrhythmias

Schürmann

Peñalver

Valderrábano

2015

Current Opinion in Cardiology

View full text Add to dashboard Cite

Introduction Ethanol infusion was an early mode of ablative treatment for cardiac arrhythmias. Its initial descriptions involved coronary intra-arterial delivery, targeting arrhythmogenic substrates in drug-refractory ventricular tachycardia or the atrioventricular node. Largely superseded by radiofrequency ablation (RFA) and other contact-based technologies as a routine ablation strategy, intracoronary arterial ethanol infusion remains as an alternative option in the treatment of ventricular tachycardia when conventional ablation fails. Arrhythmic foci that are deep-seated in the myocardium may not be amenable to catheter ablation from either the endocardium or the epicardium by RFA, but they can be targeted by an ethanol infusion. Recent findings Recently, we have explored ethanol injection through cardiac venous systems, in order to avoid the risks of complications and limitations of coronary arterial instrumentation. Vein of Marshall ethanol infusion is being studied as an adjunctive procedure in ablation of atrial fibrillation, and coronary venous ethanol infusion for ventricular tachycardia. Conclusion Ethanol ablation remains useful as a bail-out technique for refractory cases to RFA, or as an adjunctive therapy that may improve the efficacy of catheter ablation procedures.

show abstract

“…Transarterial coronary ethanol ablation (TCEA) has been well investigated in previous reports. [5][6][7][8] Intra-arterial injection of ethanol has classically delivered cytotoxic injury through vasculature supplying the target myocardial tissue. TCEA-related complications, such as coronary artery thrombosis, dissection, conduction block, and myocardial infarction, could result in serious injury, especially in patients with LV dysfunction and scar-related VTs.…”

Section: Discussionmentioning

confidence: 99%